DLRHX Holdings Information

DLRHX is a mutual fund with a total of 106 individual holdings. The top holdings are UCB SA stock at 5.73%, Regeneron Pharmaceuticals at 5.07%, Pfizer at 4.41%, Gilead Sciences at 4.34%, and Eli Lilly and Company at 4.07%.

Total Holdings

106

Top 10 Percentage

42.12%

Asset Class

Equity

Fund Category

Health

Assets

705.88M

Forward PE Ratio

15.89

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	EBR: UCB	UCB SA	5.73%	130,137
2	REGN	Regeneron Pharmaceuticals, Inc.	5.07%	47,000
3	PFE	Pfizer Inc.	4.41%	1,145,000
4	GILD	Gilead Sciences, Inc.	4.34%	210,000
5	LLY	Eli Lilly and Company	4.07%	27,000
6	ABBV	AbbVie Inc.	4.06%	125,000
7	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	3.72%	450,000
8	SWX: ROG	Roche Holding AG	3.63%	55,000
9	LON: AZN	AstraZeneca PLC	3.55%	131,243
10	MRK	Merck & Co., Inc.	3.53%	220,000
11	BSX	Boston Scientific Corporation	3.40%	250,000
12	ELV	Elevance Health, Inc.	3.17%	63,000
13	UNH	UnitedHealth Group Incorporated	2.92%	70,000
14	AMGN	Amgen Inc.	2.49%	50,000
15	HALO	Halozyme Therapeutics, Inc.	2.30%	220,000
16	VTRS	Viatris Inc.	2.23%	1,170,018
17	ILMN	Illumina, Inc.	1.90%	90,000
18	VRTX	Vertex Pharmaceuticals Incorporated	1.71%	25,000
19	EPA: SAN	Sanofi	1.64%	120,000
20	FNMA	Federal National Mortgage Association Fannie Mae	1.55%	1,300,000
21	ALNY	Alnylam Pharmaceuticals, Inc.	1.48%	30,000
22	ALKS	Alkermes plc	1.43%	290,000
23	VKTX	Viking Therapeutics, Inc.	1.39%	330,100
24	NBIX	Neurocrine Biosciences, Inc.	1.39%	70,000
25	DVAX	Dynavax Technologies Corporation	1.28%	570,000

Showing 25 of 106 holdings

Subscribe to see the full list

Activate Now

As of Jan 31, 2026